Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Randomised, Double Blind, Double Dummy, Active Comparator Controlled, Parallel Group Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis

NCT00299013 is registered in ClinicalTrials.gov with Alizyme as lead sponsor.

NCT NCT00299013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00299013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Randomised, Double Blind, Double Dummy, Active Comparator Controlled, Parallel Group Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
Lead sponsor
Alizyme
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2006
Completion date
April 30, 2008
Enrollment
796 (actual)
Sites
86

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis